TNX-601 ER
TNX-TI-M201
Phase 2 small_molecule completed
Quick answer
TNX-601 ER for Depression is a Phase 2 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Depression
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed